GT
TNXP icon

Glenmede Trust’s Tonix Pharmaceuticals TNXP Stock Holding History

Glenmede Trust’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Hold
0
– – – 2793
2017
Q3 		– Hold
0
– – – 2833
2017
Q2 		– Hold
0
– – – 2691
2017
Q1 		– Hold
0
– – – 2749
2016
Q4 		– Hold
0
– – – 2618
2016
Q3 		– Hold
0
– – – 2676
2016
Q2 		– Hold
0
– – – 2490
2016
Q1 		– Hold
0
– – – 2422
2015
Q4 		– Hold
0
– – – 2172
2015
Q3 		– Hold
0
– – – 2311
2015
Q2 		– Hold
0
– – – 2148
2015
Q1 		– Hold
0
– – – 2221
2014
Q4 		– Hold
0
– – – 2316
2014
Q3 		– Hold
0
– – – 2208
2014
Q2 		– Hold
0
– – – 1963

Other funds holding TNXP

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return